Sleep health company SleepScore Labs reported on Tuesday the completion of the acquisition of Sleep.ai and its wearable and digital app that detects snoring and bruxism.
Sleep.ai is a digital health company specialised in highly sophisticated analysis during sleep using a mobile device. The apps use special algorithms to filter and detect snoring. It offers a CE-certified app specialised in detecting teeth grinding during sleep. The app gives the option to track progress over time, and if needed, can recommend a local medical professional if the condition is of concern. Sleep.ai reportedly created an app and wearable for detecting if a user is snoring and/or grinding their teeth, known as bruxism and helps dentists monitor patients after they've begun dental treatment for either condition.
Additionally, the Sleep.ai app has been downloaded more than 250,000 times from the App Store and Google Play store and Sleep.ai apps will still be available on its own website as well as SleepScore Labs'.
Following closing, Sleep.ai's founder and CEO Michiel Allessie, a Dutch board-certified sleep dentist, will join the SleepScore Labs team in Carlsbad, Calif., as vice president of Snoring and Bruxism to continue advancing the latest technologies in detecting sleep issues.
The terms of the acquisition were not disclosed by the companies.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system